Parkinson's Disease Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014535160
Market Monitor Global
Oct-2021
Life Sciences
107 Pages

This report contains market size and forecasts of Parkinson's Disease Therapeutics in Global, including the following market information:
Global Parkinson's Disease Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Parkinson's Disease Therapeutics market was valued at 2484.9 million in 2020 and is projected to reach US$ 3106.7 million by 2027, at a CAGR of 5.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Parkinson's Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parkinson's Disease Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Parkinson's Disease Therapeutics Market Segment Percentages, By Type, 2020 (%)
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

China Parkinson's Disease Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Parkinson's Disease Therapeutics Market Segment Percentages, By Application, 2020 (%)
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

Global Parkinson's Disease Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Parkinson's Disease Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Parkinson's Disease Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Parkinson's Disease Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Parkinson's Disease Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinson's Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinson's Disease Therapeutics Overall Market Size
2.1 Global Parkinson's Disease Therapeutics Market Size: 2021 VS 2027
2.2 Global Parkinson's Disease Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Parkinson's Disease Therapeutics Players in Global Market
3.2 Top Global Parkinson's Disease Therapeutics Companies Ranked by Revenue
3.3 Global Parkinson's Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Parkinson's Disease Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Parkinson's Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Parkinson's Disease Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Parkinson's Disease Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Parkinson's Disease Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Parkinson's Disease Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Sinemet-CR
4.1.3 Trastal
4.1.4 Madopar
4.1.5 COMT Inhibitor
4.1.6 Other
4.2 By Type - Global Parkinson's Disease Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Parkinson's Disease Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Parkinson's Disease Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Parkinson's Disease Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parkinson's Disease Therapeutics Market Size, 2021 & 2027
5.1.2 Under 40 Years Old
5.1.3 40-65 Years Old
5.1.4 Above 65 Years Old
5.2 By Application - Global Parkinson's Disease Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Parkinson's Disease Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Parkinson's Disease Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Parkinson's Disease Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Parkinson's Disease Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Parkinson's Disease Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Parkinson's Disease Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Parkinson's Disease Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Parkinson's Disease Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Parkinson's Disease Therapeutics Revenue, 2016-2027
6.3.2 US Parkinson's Disease Therapeutics Market Size, 2016-2027
6.3.3 Canada Parkinson's Disease Therapeutics Market Size, 2016-2027
6.3.4 Mexico Parkinson's Disease Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Parkinson's Disease Therapeutics Revenue, 2016-2027
6.4.2 Germany Parkinson's Disease Therapeutics Market Size, 2016-2027
6.4.3 France Parkinson's Disease Therapeutics Market Size, 2016-2027
6.4.4 U.K. Parkinson's Disease Therapeutics Market Size, 2016-2027
6.4.5 Italy Parkinson's Disease Therapeutics Market Size, 2016-2027
6.4.6 Russia Parkinson's Disease Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Parkinson's Disease Therapeutics Market Size, 2016-2027
6.4.8 Benelux Parkinson's Disease Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Parkinson's Disease Therapeutics Revenue, 2016-2027
6.5.2 China Parkinson's Disease Therapeutics Market Size, 2016-2027
6.5.3 Japan Parkinson's Disease Therapeutics Market Size, 2016-2027
6.5.4 South Korea Parkinson's Disease Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Parkinson's Disease Therapeutics Market Size, 2016-2027
6.5.6 India Parkinson's Disease Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Parkinson's Disease Therapeutics Revenue, 2016-2027
6.6.2 Brazil Parkinson's Disease Therapeutics Market Size, 2016-2027
6.6.3 Argentina Parkinson's Disease Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Parkinson's Disease Therapeutics Revenue, 2016-2027
6.7.2 Turkey Parkinson's Disease Therapeutics Market Size, 2016-2027
6.7.3 Israel Parkinson's Disease Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Parkinson's Disease Therapeutics Market Size, 2016-2027
6.7.5 UAE Parkinson's Disease Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Parkinson's Disease Therapeutics Major Product Offerings
7.1.4 Merck Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Akorn
7.2.1 Akorn Corporate Summary
7.2.2 Akorn Business Overview
7.2.3 Akorn Parkinson's Disease Therapeutics Major Product Offerings
7.2.4 Akorn Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.2.5 Akorn Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Parkinson's Disease Therapeutics Major Product Offerings
7.3.4 GSK Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.3.5 GSK Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Parkinson's Disease Therapeutics Major Product Offerings
7.4.4 Novartis Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.4.5 Novartis Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Major Product Offerings
7.5.4 Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.5.5 Boehringer Ingelheim Key News
7.6 Teva Pharmaceutical
7.6.1 Teva Pharmaceutical Corporate Summary
7.6.2 Teva Pharmaceutical Business Overview
7.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Major Product Offerings
7.6.4 Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.6.5 Teva Pharmaceutical Key News
7.7 Abbvie
7.7.1 Abbvie Corporate Summary
7.7.2 Abbvie Business Overview
7.7.3 Abbvie Parkinson's Disease Therapeutics Major Product Offerings
7.4.4 Abbvie Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.7.5 Abbvie Key News
7.8 Kyowa Hakko Kirin Pharma
7.8.1 Kyowa Hakko Kirin Pharma Corporate Summary
7.8.2 Kyowa Hakko Kirin Pharma Business Overview
7.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Major Product Offerings
7.8.4 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.8.5 Kyowa Hakko Kirin Pharma Key News
7.9 Astellas Pharma
7.9.1 Astellas Pharma Corporate Summary
7.9.2 Astellas Pharma Business Overview
7.9.3 Astellas Pharma Parkinson's Disease Therapeutics Major Product Offerings
7.9.4 Astellas Pharma Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.9.5 Astellas Pharma Key News
7.10 Roche
7.10.1 Roche Corporate Summary
7.10.2 Roche Business Overview
7.10.3 Roche Parkinson's Disease Therapeutics Major Product Offerings
7.10.4 Roche Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.10.5 Roche Key News
7.11 H.Lundbeck
7.11.1 H.Lundbeck Corporate Summary
7.11.2 H.Lundbeck Business Overview
7.11.3 H.Lundbeck Parkinson's Disease Therapeutics Major Product Offerings
7.11.4 H.Lundbeck Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.11.5 H.Lundbeck Key News
7.12 Bausch Health
7.12.1 Bausch Health Corporate Summary
7.12.2 Bausch Health Business Overview
7.12.3 Bausch Health Parkinson's Disease Therapeutics Major Product Offerings
7.12.4 Bausch Health Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.12.5 Bausch Health Key News
7.13 Apokyn
7.13.1 Apokyn Corporate Summary
7.13.2 Apokyn Business Overview
7.13.3 Apokyn Parkinson's Disease Therapeutics Major Product Offerings
7.13.4 Apokyn Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.13.5 Apokyn Key News
7.14 Orion
7.14.1 Orion Corporate Summary
7.14.2 Orion Business Overview
7.14.3 Orion Parkinson's Disease Therapeutics Major Product Offerings
7.14.4 Orion Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.14.5 Orion Key News
7.15 Stada Arzneimittel
7.15.1 Stada Arzneimittel Corporate Summary
7.15.2 Stada Arzneimittel Business Overview
7.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Major Product Offerings
7.15.4 Stada Arzneimittel Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.15.5 Stada Arzneimittel Key News
7.16 US WorldMeds
7.16.1 US WorldMeds Corporate Summary
7.16.2 US WorldMeds Business Overview
7.16.3 US WorldMeds Parkinson's Disease Therapeutics Major Product Offerings
7.16.4 US WorldMeds Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.16.5 US WorldMeds Key News
7.17 Desitin Arzneimittel
7.17.1 Desitin Arzneimittel Corporate Summary
7.17.2 Desitin Arzneimittel Business Overview
7.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Major Product Offerings
7.17.4 Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.17.5 Desitin Arzneimittel Key News
7.18 Endo Pharmaceuticals
7.18.1 Endo Pharmaceuticals Corporate Summary
7.18.2 Endo Pharmaceuticals Business Overview
7.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Major Product Offerings
7.18.4 Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue in Global (2016-2021)
7.18.5 Endo Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Parkinson's Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Parkinson's Disease Therapeutics Market Drivers in Global Market
Table 3. Parkinson's Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Parkinson's Disease Therapeutics in Global Market
Table 5. Top Parkinson's Disease Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Parkinson's Disease Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Parkinson's Disease Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Parkinson's Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Parkinson's Disease Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinson's Disease Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE